Cargando…

Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study

The human oral microbiome (HOM) is the second largest microbial community after the gut and can impact the onset and progression of several localized and systemic diseases, including those of viral origin, especially for viruses entering the body via the oropharynx. However, this important aspect ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Soffritti, Irene, D’Accolti, Maria, Fabbri, Chiara, Passaro, Angela, Manfredini, Roberto, Zuliani, Giovanni, Libanore, Marco, Franchi, Maurizio, Contini, Carlo, Caselli, Elisabetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261071/
https://www.ncbi.nlm.nih.gov/pubmed/34248910
http://dx.doi.org/10.3389/fmicb.2021.687513
_version_ 1783718937631916032
author Soffritti, Irene
D’Accolti, Maria
Fabbri, Chiara
Passaro, Angela
Manfredini, Roberto
Zuliani, Giovanni
Libanore, Marco
Franchi, Maurizio
Contini, Carlo
Caselli, Elisabetta
author_facet Soffritti, Irene
D’Accolti, Maria
Fabbri, Chiara
Passaro, Angela
Manfredini, Roberto
Zuliani, Giovanni
Libanore, Marco
Franchi, Maurizio
Contini, Carlo
Caselli, Elisabetta
author_sort Soffritti, Irene
collection PubMed
description The human oral microbiome (HOM) is the second largest microbial community after the gut and can impact the onset and progression of several localized and systemic diseases, including those of viral origin, especially for viruses entering the body via the oropharynx. However, this important aspect has not been clarified for the new pandemic human coronavirus SARS-CoV-2, causing COVID-19 disease, despite it being one of the many respiratory viruses having the oropharynx as the primary site of replication. In particular, no data are available about the non-bacterial components of the HOM (fungi, viruses), which instead has been shown to be crucial for other diseases. Consistent with this, this study aimed to define the HOM in COVID-19 patients, to evidence any association between its profile and the clinical disease. Seventy-five oral rinse samples were analyzed by Whole Genome Sequencing (WGS) to simultaneously identify oral bacteria, fungi, and viruses. To correlate the HOM profile with local virus replication, the SARS-CoV-2 amount in the oral cavity was quantified by digital droplet PCR. Moreover, local inflammation and secretory immune response were also assessed, respectively by measuring the local release of pro-inflammatory cytokines (L-6, IL-17, TNFα, and GM-CSF) and the production of secretory immunoglobulins A (sIgA). The results showed the presence of oral dysbiosis in COVID-19 patients compared to matched controls, with significantly decreased alpha-diversity value and lower species richness in COVID-19 subjects. Notably, oral dysbiosis correlated with symptom severity (p = 0.006), and increased local inflammation (p < 0.01). In parallel, a decreased mucosal sIgA response was observed in more severely symptomatic patients (p = 0.02), suggesting that local immune response is important in the early control of virus infection and that its correct development is influenced by the HOM profile. In conclusion, the data presented here suggest that the HOM profile may be important in defining the individual susceptibility to SARS-CoV-2 infection, facilitating inflammation and virus replication, or rather, inducing a protective IgA response. Although it is not possible to determine whether the alteration in the microbial community is the cause or effect of the SARS-CoV-2 replication, these parameters may be considered as markers for personalized therapy and vaccine development.
format Online
Article
Text
id pubmed-8261071
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82610712021-07-08 Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study Soffritti, Irene D’Accolti, Maria Fabbri, Chiara Passaro, Angela Manfredini, Roberto Zuliani, Giovanni Libanore, Marco Franchi, Maurizio Contini, Carlo Caselli, Elisabetta Front Microbiol Microbiology The human oral microbiome (HOM) is the second largest microbial community after the gut and can impact the onset and progression of several localized and systemic diseases, including those of viral origin, especially for viruses entering the body via the oropharynx. However, this important aspect has not been clarified for the new pandemic human coronavirus SARS-CoV-2, causing COVID-19 disease, despite it being one of the many respiratory viruses having the oropharynx as the primary site of replication. In particular, no data are available about the non-bacterial components of the HOM (fungi, viruses), which instead has been shown to be crucial for other diseases. Consistent with this, this study aimed to define the HOM in COVID-19 patients, to evidence any association between its profile and the clinical disease. Seventy-five oral rinse samples were analyzed by Whole Genome Sequencing (WGS) to simultaneously identify oral bacteria, fungi, and viruses. To correlate the HOM profile with local virus replication, the SARS-CoV-2 amount in the oral cavity was quantified by digital droplet PCR. Moreover, local inflammation and secretory immune response were also assessed, respectively by measuring the local release of pro-inflammatory cytokines (L-6, IL-17, TNFα, and GM-CSF) and the production of secretory immunoglobulins A (sIgA). The results showed the presence of oral dysbiosis in COVID-19 patients compared to matched controls, with significantly decreased alpha-diversity value and lower species richness in COVID-19 subjects. Notably, oral dysbiosis correlated with symptom severity (p = 0.006), and increased local inflammation (p < 0.01). In parallel, a decreased mucosal sIgA response was observed in more severely symptomatic patients (p = 0.02), suggesting that local immune response is important in the early control of virus infection and that its correct development is influenced by the HOM profile. In conclusion, the data presented here suggest that the HOM profile may be important in defining the individual susceptibility to SARS-CoV-2 infection, facilitating inflammation and virus replication, or rather, inducing a protective IgA response. Although it is not possible to determine whether the alteration in the microbial community is the cause or effect of the SARS-CoV-2 replication, these parameters may be considered as markers for personalized therapy and vaccine development. Frontiers Media S.A. 2021-06-23 /pmc/articles/PMC8261071/ /pubmed/34248910 http://dx.doi.org/10.3389/fmicb.2021.687513 Text en Copyright © 2021 Soffritti, D’Accolti, Fabbri, Passaro, Manfredini, Zuliani, Libanore, Franchi, Contini and Caselli. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Soffritti, Irene
D’Accolti, Maria
Fabbri, Chiara
Passaro, Angela
Manfredini, Roberto
Zuliani, Giovanni
Libanore, Marco
Franchi, Maurizio
Contini, Carlo
Caselli, Elisabetta
Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study
title Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study
title_full Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study
title_fullStr Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study
title_full_unstemmed Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study
title_short Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study
title_sort oral microbiome dysbiosis is associated with symptoms severity and local immune/inflammatory response in covid-19 patients: a cross-sectional study
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261071/
https://www.ncbi.nlm.nih.gov/pubmed/34248910
http://dx.doi.org/10.3389/fmicb.2021.687513
work_keys_str_mv AT soffrittiirene oralmicrobiomedysbiosisisassociatedwithsymptomsseverityandlocalimmuneinflammatoryresponseincovid19patientsacrosssectionalstudy
AT daccoltimaria oralmicrobiomedysbiosisisassociatedwithsymptomsseverityandlocalimmuneinflammatoryresponseincovid19patientsacrosssectionalstudy
AT fabbrichiara oralmicrobiomedysbiosisisassociatedwithsymptomsseverityandlocalimmuneinflammatoryresponseincovid19patientsacrosssectionalstudy
AT passaroangela oralmicrobiomedysbiosisisassociatedwithsymptomsseverityandlocalimmuneinflammatoryresponseincovid19patientsacrosssectionalstudy
AT manfrediniroberto oralmicrobiomedysbiosisisassociatedwithsymptomsseverityandlocalimmuneinflammatoryresponseincovid19patientsacrosssectionalstudy
AT zulianigiovanni oralmicrobiomedysbiosisisassociatedwithsymptomsseverityandlocalimmuneinflammatoryresponseincovid19patientsacrosssectionalstudy
AT libanoremarco oralmicrobiomedysbiosisisassociatedwithsymptomsseverityandlocalimmuneinflammatoryresponseincovid19patientsacrosssectionalstudy
AT franchimaurizio oralmicrobiomedysbiosisisassociatedwithsymptomsseverityandlocalimmuneinflammatoryresponseincovid19patientsacrosssectionalstudy
AT continicarlo oralmicrobiomedysbiosisisassociatedwithsymptomsseverityandlocalimmuneinflammatoryresponseincovid19patientsacrosssectionalstudy
AT casellielisabetta oralmicrobiomedysbiosisisassociatedwithsymptomsseverityandlocalimmuneinflammatoryresponseincovid19patientsacrosssectionalstudy